Three Innovation Fellows have been appointed, including two at the Royal Veterinary College (RVC), to undertake studies aimed at producing new diagnostic tools for infectious diseases. These fellowship appointments are sponsored by The Bloomsbury SET (standing for ‘Science, Economics and Technology’) – a £5 million research programme funded by Research England’s Connecting Capability Fund to deliver on the objectives of the UK Government’s Industrial Strategy.
The Bloomsbury SET adopts a One Health approach to the development of new vaccines, diagnostic tools and mathematical models to combat infectious diseases and antimicrobial resistance. Fellows are encouraged to turn scientific research into practical tools with real world applications. Bloomsbury SET supports the early career researchers through both tailored guidance and grant funding. It is hoped their work will be used to develop tangible improvements to the welfare of humans and animals.
The three Fellows and their project titles are:
- Dr Laura Buggiotti (RVC) – ‘Mining RNA unmapped reads: developing a fast-diagnostic tool for infectious disease in cattle’ (Grant value: £302,878)
- Dr Ben Swift (RVC) – ‘Bacteriophage technology: rapid point-of-care detection and antibiotic resistance profiling of tuberculosis infections’ (Grant value: £346,124)
- Dr Kevin Tetteh (London School of Hygiene and Tropical Medicine) – ‘Development of a suspension bead assay targeting the zoonotic malaria parasite’ (Grant value: £334,943)
As well as the RVC and LSHTM, Bloomsbury SET is also made up of the LSE, the London International Development Centre (LIDC), and SOAS University of London. This announcement takes the total number of projects funded by The Bloomsbury SET to six, meaning it has distributed approximately £1.8 million in grant funding since April 2018.
Welcoming the announcement of the awards, Professor Claire Heffernan, Professor of International Development at RVC and Director at the London International Development Centre, commented:
“The Bloomsbury SET capitalises on our Colleges’ world-leading expertise in infectious disease and supports our ability to transform research into tangible health outcomes. By supporting early and mid-career researchers, we offer a pathway for the best ideas to merge into sustainable solutions.”